His research interests include:
(a) Circadian biology, metabolism, and ageing
(b) Regulation, safety, and efficacy of functional foods and nutraceuticals
(c) Discerning the role of lipid mediators such as eicosanoids and platelet-activating factors in inflammatory diseases.
(d) The role of a patient's nutritional status and the use of supplements during COVID-19.
Check out the webpage for research, science communication and how to make contact.
Himel Mondal, Emil D. Parvanov, Rajeev K. Singla, R. Rayan, F. Nawaz, V. Ritschl, F. Eibensteiner, Chandragiri Siva Sai, M. Cenanovic, Hari Prasad Devkota, M. Hribersek, Ronita De, E. Klager, M. Kletečka-Pulker, S. Völkl-Kernstock, G. Khalid, R. Lordan, M. Găman, Bairong Shen, T. Stamm, H. Willschke, Atanas G. Atanasov
Frontiers in Medicine, 2022
H. M. Rando, R. Lordan, Alexandra J. Lee, A. Naik, Nils Wellhausen, Elizabeth A Sell, Likhitha Kolla, COVID-19 Review Consortium, A. Gitter, Casey S. Greene
H. Rando, A. Maclean, Alexandra J. Lee, R. Lordan, Sandipan Ray, Vikas Bansal, Ashwin N. Skelly, Elizabeth A Sell, J. Dziak, Lamonica Shinholster, Lucy D’Agostino McGowan, Marouen Ben Guebila, Nils Wellhausen, S. Knyazev, S. Boca, Stephen Capone, Yanjun Qi, YoSon Park, David Mai, Yuchen Sun, J. Boerckel, Christian Brueffer, James Brian Byrd, J. Kamil, Jinhui Wang, Ryan Velazquez, G. Szeto, J. Barton, R. Goel, S. Mangul, Tiago Lubiana, A.B.D. Gitter, C. Greene
H. Rando, Christian Brueffer, R. Lordan, A. A. Dattoli, D. Manheim, J. Meyer, Ariel I. Mundo, Dimitri Perrin, David Mai, Nils Wellhausen, A.B.D. Gitter, Casey S. Greene
Katie Shiels, A. Tsoupras, R. Lordan, I. Zabetakis, Patrick Murray, Sushanta Kumar Saha
Journal of Functional Foods, 2022
R. Lordan, A. Tsoupras, I. Zabetakis
Methods in molecular biology, 2022
Sandrayee Brahma, A. Naik, R. Lordan
Clinical Nutrition ESPEN, 2022
2020 - Present: This project aims to understand the role of circadian misalignment and its contribution to metabolic diseases and aging, with a focus on Bmal1.
2016 - Present: Platelet-activating factor (PAF), prostaglandins, and leukotrienes play a pivotal role in inflammatory signaling. We are interested in the development of novel therapeutic agents targeting these inflammatory mediators.
2020 - 2021: COVID-19 Review Consortium at UPenn. Our aim is to distill the existing COVID-19 literature into reviews that document the most reliable research to date in the areas of pathogenesis, therapeutics, prophylactics, and diagnostics.
The aim of this project was to assess the antioxidant properties and elucidate the structures of antithrombotic polar lipids from farmed Atlantic salmon using C30RP-UHPLC-HRAM-MS/MS for the development of novel nutraceuticals.
Dr Ronan Lordan
Available to discuss new collaborations, science outreach or speaking opportunities. Feel free to make contact via email or twitter.
Institute for Translational Medicine and Therapeutics